← Open Payments lookup

EMILY DRINKWARD: Open Payments

NPI 1770298267 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,723 in 114 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,260 · 2025 $3,723

Food & beverage: $3,559Education: $164
CompanyPaymentsAmount
GENZYME CORPORATION14$847
GlaxoSmithKline, LLC.22$618
AstraZeneca Pharmaceuticals LP15$583
Boehringer Ingelheim Pharmaceuticals, Inc.18$552
Grifols USA, LLC12$252
Insmed, Inc.13$188
Merck Sharp & Dohme LLC4$184
Regeneron Healthcare Solutions, Inc.3$135
Mallinckrodt Hospital Products Inc.3$106
Verona Pharma, Inc.4$84

Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, Prolastin-C Liquid, OFEV, WINREVAIR, TEZSPIRE, Arikayce.

Industry payments across CA — which companies pay providers there.